Citation: Lj. Strausbaugh et al., National shortages of antimicrobial agents: Results of 2 surveys from the Infectious Diseases Society of America Emerging Infections Network, CLIN INF D, 33(9), 2001, pp. 1495-1501
Authors:
Kami, M
Fukui, T
Ogawa, S
Kazuyama, Y
Machida, U
Tanaka, Y
Kanda, Y
Kashima, T
Yamazaki, Y
Hamaki, T
Mori, S
Akiyama, H
Mutou, Y
Sakamaki, H
Osumi, K
Kimura, S
Hirai, H
Citation: M. Kami et al., Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis, CLIN INF D, 33(9), 2001, pp. 1504-1512
Authors:
de Silva, GDI
Justice, A
Wilkinson, AR
Buttery, J
Herbert, M
Day, NPJ
Peacock, SJ
Citation: Gdi. De Silva et al., Genetic population structure of coagulase-negative staphylococci associated with carriage and disease in preterm infants, CLIN INF D, 33(9), 2001, pp. 1520-1528
Authors:
Villanueva, A
Arathoon, EG
Gotuzzo, E
Berman, RS
DiNubile, MJ
Sable, CA
Citation: A. Villanueva et al., A randomized double-blind study of caspofungin versus amphotericin for thetreatment of candidal esophagitis, CLIN INF D, 33(9), 2001, pp. 1529-1535
Citation: Ra. Hajjeh et Dw. Warnock, Counterpoint: Invasive aspergillosis and the environment - Rethinking our approach to prevention, CLIN INF D, 33(9), 2001, pp. 1549-1552
Citation: K. Leder et al., Travel vaccines and elderly persons: Review of vaccines available in the United States, CLIN INF D, 33(9), 2001, pp. 1553-1566
Authors:
Howard, D
Cordell, R
McGowan, JE
Packard, RM
Scott, RD
Solomon, SL
Elbasha, EH
Gerberding, JL
Meltzer, MI
Weber, JT
Rajbhandary, S
Steinberg, JP
Flanders, WD
Florence, CS
Roberts, R
Weinstein, RA
Goss, TF
Song, XY
Roghmann, MC
Bradham, DD
South, BR
Bellm, LA
Mulligan, MLE
Porter, SB
Teutsch, S
Callahan, M
Saint, S
Rosenman, R
Fraser, VJ
Citation: D. Howard et al., Measuring the economic costs of antimicrobial resistance in hospital settings: Summary of the Centers for Disease Control and Prevention - Emory workshop, CLIN INF D, 33(9), 2001, pp. 1573-1578
Authors:
Torre, D
Tambini, R
Cadario, F
Barbarini, G
Moroni, M
Basilico, C
Citation: D. Torre et al., Evolution of coinfection with human immunodeficiency virus and hepatitis Cvirus in patients treated with highly active antiretroviral therapy, CLIN INF D, 33(9), 2001, pp. 1579-1585
Authors:
Paddock, CD
Folk, SM
Shore, GM
Machado, LJ
Huycke, MM
Slater, LN
Liddell, AM
Buller, RS
Storch, GA
Monson, TP
Rimland, D
Sumner, JW
Singleton, J
Bloch, KC
Tang, YW
Standaert, SM
Childs, JE
Citation: Cd. Paddock et al., Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus, CLIN INF D, 33(9), 2001, pp. 1586-1594
Authors:
Clarke, SM
Mulcahy, FM
Tjia, J
Reynolds, HE
Gibbons, SE
Barry, MG
Back, DJ
Citation: Sm. Clarke et al., Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users, CLIN INF D, 33(9), 2001, pp. 1595-1597
Authors:
Wagner, J
Ignatius, R
Voss, S
Hopfner, V
Ehlers, S
Funke, G
Weber, U
Hahn, H
Citation: J. Wagner et al., Infection of the skin caused by Corynebacterium ulcerans and mimicking classical cutaneous diphtheria, CLIN INF D, 33(9), 2001, pp. 1598-1600
Authors:
Fijen, JW
Tulleken, JE
Hepkema, BG
van der Werf, TS
Ligtenberg, JJM
Zijlstra, JG
Citation: Jw. Fijen et al., The influence of tumor necrosis factor-alpha and interleukin-10 gene promoter polymorphism on the inflammatory response in experimental human endotoxemia, CLIN INF D, 33(9), 2001, pp. 1601-1603
Authors:
Seppanen, M
Lokki, ML
Timonen, T
Lappalainen, M
Jarva, H
Jarvinen, A
Sarna, S
Valtonen, V
Meri, S
Citation: M. Seppanen et al., Complement C4 deficiency and HLA homozygosity in patients with frequent intraoral herpes simplex virus type 1 infections, CLIN INF D, 33(9), 2001, pp. 1604-1607
Authors:
Maggi, P
Larocca, AMV
Ladisa, N
Carbonara, S
Brandonisio, O
Angarano, G
Pastore, G
Citation: P. Maggi et al., Opportunistic parasitic infections of the intestinal tract in the era of highly active antiretroviral therapy: Is the CD4(+) count so important?, CLIN INF D, 33(9), 2001, pp. 1609-1611